generating consistent returns across market environments requires a DEI approach to portfolio construction:Hype - chinese founderLaunch - jewish founderIP - korean founderBTC - indian founder ...

Republican Senator Bill Cassidy and Democratic Senator Tim Kaine are hoping to uh to help rescue Social Security. In a Washington Post oped this week, the senators proposed diversifying trust fund investments in order to maintain uh benefits. Senator Bill Cassidy joins us this morning.He chairs uh the health commiss commission. Senator, this is been bandied about for for for years, I think. What what's the current um investment just for people that that aren't familiar.What's it invested in now. What's the ...

Our newsmaker this hour, Dr. . Marty McCary, the FDA commissioner, marking his first 100 days on the job. It's been a busy few months with many changes at the agency from vaccines to staffing.Good morning, uh, doctor. Good morning, Joe. I don't maybe you've been on a few time.I don't I I don't remember, but we all went through uh that that period together, obviously, and and there's a lot of u of of a look back now at at at that period. you know, it's, you know, it's a it's a hot button issue and sometimes ...

India’s roads are dangerous, especially to pedestrians. Improving roads would speed up travel, reduce noise pollution, cut emissions and increase productivity https://t.co/x9EK8X71uF ...

ATLANTA, July 10, 2025 (GLOBE NEWSWIRE) -- Gray Media and the NFL’s Carolina Panthers are proud to announce a first---a new partnership that will bring all three Panthers preseason games live in Spanish to Gray’s Telemundo audience across the Carolinas. Starting this August, Spanish-speaking fans will be able to catch every Panthers preseason game on six Gray Telemundo affiliate stations in South Carolina and Eastern North Carolina. Telemundo stations airing Panthers preseason games include: WDKT – Greenvil ...

Summary of Processa Pharmaceuticals (PCSA) Update / Briefing July 09, 2025 Company Overview - **Company**: Processa Pharmaceuticals - **Ticker**: PCSA - **Industry**: Pharmaceuticals, specifically oncology drug development Core Points and Arguments 1. **Derisked Approach**: Processa Pharmaceuticals adopts a derisked approach to drug development, focusing on improving existing cancer therapies rather than creating entirely new drugs. This strategy aims to enhance efficacy and safety of current treatments [15][29][40] 2. **Regulatory Science**: The company has a proprietary regulatory science approach that has led to 30 regulatory approvals, aligning with FDA's new project optimist requirements for oncology drugs [15][16][30] 3. **Pipeline Overview**: - **PCS 6422**: A combination therapy with capecitabine, showing a 67% response rate in a phase 1b trial, significantly higher than the 20-40% response rate for capecitabine alone. The drug also demonstrated better safety, with only 6% of patients experiencing hand and foot syndrome compared to 50% for capecitabine alone [18][19][34] - **PCS 11T**: An altered version of SN-38, aiming to reduce off-target effects and improve safety by preferentially drawing the drug into tumor cells. The goal is to potentially remove black box warnings associated with existing drugs [22][35] - **PCS 12852**: Recently partnered with Intact Therapeutics, with a deal valued at approximately $454 million, including milestone payments and royalties [24][25] - **PCS 499**: Pivoting back to renal and nephropathy space, with plans for a phase 3 adaptive study, potentially being the only drug in its category without a black box warning [26][27][45] Market Position and Competitive Advantage 1. **High Unmet Need**: Despite advancements in oncology, cancer remains the second leading cause of death, indicating a significant market opportunity for better therapies [16] 2. **Competitive Differentiation**: Processa's derisked approach allows it to focus on enhancing existing therapies, which is seen as a lower bar compared to developing new drugs from scratch. This strategy is supported by a seasoned management team with extensive experience in public companies and regulatory approvals [30][40][48] 3. **Strategic Partnerships**: The company is actively seeking partnerships to accelerate drug development, particularly for PCS 499 and oncology assets, with ongoing discussions with major players in the renal space [44][46] Upcoming Catalysts 1. **Phase 2 Preliminary Analysis**: Expected results for PCS 6422 in the second half of the year, which could provide significant data for future partnerships [31][49] 2. **FDA Interactions**: Ongoing engagement with the FDA regarding study protocols and potential approvals, particularly for PCS 499 and the phase 2 study for PCS 6422 [41][43] Additional Important Information 1. **Market Potential**: The ability to make capecitabine safer and more effective could expand the patient population, particularly among those who are currently not prescribed the drug due to its side effects [34][38] 2. **Investor Sentiment**: The CEO expressed confidence in the company's undervaluation and the potential for significant returns due to the derisked approach and multiple drug candidates in the pipeline [47][48] This summary encapsulates the key points from the Processa Pharmaceuticals update, highlighting the company's strategic focus, pipeline developments, and market positioning within the oncology sector.

Lipocine (LPCN) Update / Briefing July 09, 2025 11:00 AM ET Speaker0Good day, ladies and gentlemen, and welcome to the call to discuss the neurobiology of postpartum depression, the treatment landscape in LPCN eleven fifty four, a short duration treatment option for PPD, which is currently in Phase III. At this time, all participants are in a listen only mode. Later, we will conduct a question and answer session. Instructions will follow the presentation at that time. As a reminder, this conference call is ...

The "Global Mayors' Dialogue·SCO Summit Cities" event was held in Tianjin on Tuesday. Gulnar Shaimergenova, director of the China Studies Center in Kazakhstan, said in an exclusive interview with China News Network that China plays a vital role in promoting regional security, cooperation, and shared development through multilateral platforms such as the Belt and Road Initiative (BRI) and the Shanghai Cooperation Organization (SCO). 7月8日,"世界市长对话·上合峰会城市"活动在天津举行。哈萨克斯坦中国研究中心主任古丽娜尔·沙伊梅 尔格诺娃(Gulnar Shaimergenova) ...

Core Insights - Glo Fiber, powered by Shenandoah Telecommunications Company (Shentel), is expanding its fiber-to-the-home (FTTH) broadband services to over 2,600 additional homes in New Market and Walkersville, Maryland, with construction expected to be completed in 2026 [1] - The company currently provides high-speed internet to more than 15,000 homes and businesses in the Frederick market, emphasizing its commitment to delivering reliable and future-proof broadband services [1][5] - Glo Fiber offers symmetrical upload and download speeds of up to 5 Gbps, leveraging a 17,200-mile regional fiber network to ensure low latency and high reliability [3][6] Company Overview - Glo Fiber provides next-generation FTTH multi-gigabit broadband internet access, live streaming TV, and digital phone services, now available to approximately 363,000 homes and businesses [5] - The company is recognized for its superior local customer service and straightforward pricing without long-term contracts [9] - Shenandoah Telecommunications Company (Shentel) operates an extensive regional network, offering various services including broadband internet, video, voice, and managed network services [6]

Haibin Zhu (852) 2800-7039 haibin.zhu@jpmorgan.com J P M O R G A N Asia Pacific Economic Research 04 July 2025 China: A preview of the July Politburo meeting We have now entered July, another eventful month. On the external front, US trade negotiations with China (the 90-day window ends in early August) and other trading partners (90-day window ends on July 9) may come up with new developments that affect international trade. On the domestic front, the 2Q GDP report will be released on July 15, followed by ...